SCHEMBL22259409

SCHEMBL22259409

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3cccc(-c4ccccc4N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
APP P05067 1/20 0.36
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ATM Q13315 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
TLR9 Q9NR96 1/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24224732 0.96 ALDH1A1 (0.41) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL17567344 0.95 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL17567346 0.95 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL23437377 0.95 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL17705330 0.95 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL17567348 0.95 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL13854539 0.95 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL17471798 0.93 L3MBTL1 (0.38) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL16385444 0.93 L3MBTL1 (0.38) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL15038387 0.93 MAPT (0.37) L3MBTL1ALDH1A1MAPTKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200231534-A1 ARYLDIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200231534-A1 ARYLDIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT FTO, SLC19A1, ALKBH1 L3MBTL1 683/4885ALDH1A1 139/4885MAPT 1146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.